Implanon®: User views in the first year across three family planning services in the Trent Region, UK

European Journal of Contraception and Reproductive Health Care

Volumn 8, Issue 1, 2003, Pages 27-36

  Reuter, S ^a   Smith, A ^b  

^a Doncaster Family Planning Service   (United Kingdom)

^b Chequer Road Clinic ^*

Author keywords

Implanon ; User perceptions; User satisfaction

Indexed keywords

ETONOGESTREL; 3 KETO DESOGESTREL; 3-KETO-DESOGESTREL; CONTRACEPTIVE AGENT; DESOGESTREL; VINYL DERIVATIVE;

ARTICLE; FAMILY PLANNING; FEMALE; HEADACHE; HUMAN; MENSTRUATION DISORDER; MOOD; NORMAL HUMAN; PATIENT ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED KINGDOM; WEIGHT GAIN; ADULT; PATIENT SATISFACTION;

ADULT; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; FEMALE; GREAT BRITAIN; HUMANS; PATIENT SATISFACTION; QUESTIONNAIRES; VINYL COMPOUNDS;

EID: 0037353732     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.1080/ejc.8.1.27.36     Document Type: Article

References (17)

1. Implanon® training manual for clinicians, NV Organon, Oss, The Netherlands
2. Oloto E, Mascharenhas L. Subdermal contraceptive implants. FACT. Br J Fam Plann 2000;26:171-4
3. Edwards J, Moore A. Implanon®. A review of clinical studies. Br J Fam Plann 1999;24(Suppl):3-16
4. Croxatto HB, Urbancsek J, Massai R, et al. A multicentre efficacy and safety study of the single contraceptive implant Implanon®. Implanon Study Group. Hum Reprod 1999;14:976-81
5. Mascharenhas L. Insertion and removal of Implanon®. Contraception 1998;58(Suppl):79-83S
6. Phillips CJ. Economic analysis of long term reversible contraceptives. Focus on Implanon®. PharmacoEcon 2000;17:209-10
7. Darney P, Atikinson E, McPerson S, et al. Acceptance and perceptions of Norplant among users m San Francisco, USA. Stud Fam Plann 1990;21:152-60
8. Fowler P. Norplant - a GP's perspective one year on. Br J Fam Plann 1995;21(Suppl 1):8-11
9. Coutinho E, Athayde C, Barbosa I, et al. Results of a user satisfaction study carried out in women using Uniplant contraceptive implant. Contraception 1996;54: 313-17
10. Blain S, Lovelady J, Oloto E, et al. Reasons for commencing and discontinuing contraception with Norplant - a review of local experience. Br J Fam Plann 1995;21 (Suppl 1):17-20
11. Ortayli N. User's perspectives on implantable contraceptives for women. Contraception 2002;65:107-11
12. Oddens BJ. Women's satisfaction with birth control: a population survey of physical & psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning and sterilisation among 1466 women. Contraception 1999;59:277-86
13. Zimmermann M, Haffey J, Crane E, et al. Assessing the acceptability of Norplant implants in four countries: finds from focus group research. Stud Fam Plann 1990; 21:92-103
14. Tanfer K, Wierzbicki S, Payn B. Why are US women not using long-acting contraceptives? Fam Plan Perspect 2000;32:176-83, 191
15. Affandi B. An integrated analysis of vaginal bleeding patterns m clinical trials of Implanon®. Contraception 1998;58:99-107S
16. Davie JE, Walling MR, Mansour DJ, et al. Impact of patient counselling on acceptance of the levonorgestrel implant contraceptive in the United Kingdom. Clin Ther 1996;18:150-9
17. den Tonkelaar I, Oddens BJ. Factors influencing women's satisfaction with birth control methods. Eur J Contracept Reprod Health Care 2001;6:153-8